tiprankstipranks
Advertisement
Advertisement
Jade Biosciences price target raised to $23 from $17 at Guggenheim
PremiumThe FlyJade Biosciences price target raised to $23 from $17 at Guggenheim
26d ago
Jade: Differentiated IgAN Profile and Multi-Asset Upside Make $2B Peak Sales for JADE101 Look Conservative
Premium
Ratings
Jade: Differentiated IgAN Profile and Multi-Asset Upside Make $2B Peak Sales for JADE101 Look Conservative
28d ago
Positioning Jade Biosciences as a Leading APRIL Inhibitor Play in IgA Nephropathy With Compelling Pipeline and Risk‑Reward
Premium
Ratings
Positioning Jade Biosciences as a Leading APRIL Inhibitor Play in IgA Nephropathy With Compelling Pipeline and Risk‑Reward
1M ago
Jade Biosciences Outlines 2026 Autoimmune Pipeline Priorities
PremiumCompany AnnouncementsJade Biosciences Outlines 2026 Autoimmune Pipeline Priorities
3M ago
Jade Biosciences outlines key 2026 objectives, strategy
Premium
The Fly
Jade Biosciences outlines key 2026 objectives, strategy
3M ago
Jade Biosciences files to sell 3.21M shares of common stock for holders
Premium
The Fly
Jade Biosciences files to sell 3.21M shares of common stock for holders
3M ago
Jade Biosciences Advances Autoimmune Therapies
PremiumCompany AnnouncementsJade Biosciences Advances Autoimmune Therapies
5M ago
Jade Biosciences files to sell 16.13M shares of common stock for holders
Premium
The Fly
Jade Biosciences files to sell 16.13M shares of common stock for holders
5M ago
Jade Biosciences Reports Q3 2025 Financial Results
Premium
Company Announcements
Jade Biosciences Reports Q3 2025 Financial Results
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100